Conditioning with sevoflurane in liver transplantation: Results of a multicenter randomized controlled trial

Transplantation

Volumn 99, Issue 8, 2015, Pages 1606-1612

  Beck Schimmer, Beatrice ^a   Bonvini, John M ^a   Schadde, Erik ^b   Dutkowski, Philipp ^b   Oberkofler, Christian E ^b   Lesurtel, Mickael ^b   DeOliveira, Michelle L ^b   Figueira, Estela R R ^c   Filho, Joel A Rocha ^c   Auler, Jose Otavio Costa ^c   D'Albuquerque, Luiz A C ^c   Reyntjens, Koen ^d   Wouters, Patrick ^d   Rogiers, Xavier ^d   Debaerdemaeker, Luc ^d   Ganter, Michael T ^a   Weber, Achim ^b   Puhan, Milo A ^e,f   Clavien, Pierre Alain ^b   Breitenstein, Stefan ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; ATRACURIUM BESILATE; FENTANYL; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; BIOLOGICAL MARKER; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CADAVER DONOR; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; LIVER INJURY; LIVER PROTECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; ADVERSE EFFECTS; BELGIUM; BLOOD; BRAZIL; CLINICAL TRIAL; COMPARATIVE STUDY; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; MORTALITY; PRIMARY GRAFT DYSFUNCTION; PROCEDURES; RISK; RISK FACTOR; SWITZERLAND; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ASPARTATE AMINOTRANSFERASES; BELGIUM; BIOLOGICAL MARKERS; BRAZIL; FEMALE; HOSPITAL MORTALITY; HUMANS; LIVER TRANSPLANTATION; MALE; METHYL ETHERS; MIDDLE AGED; ODDS RATIO; PRIMARY GRAFT DYSFUNCTION; PROPOFOL; RISK FACTORS; SWITZERLAND; TIME FACTORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 84942416899     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000644     Document Type: Article

References (34)

1. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007; 356(15):1545-1559.
2. De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S. Interventions to improve medication-adherence after transplantation: a systematic review. Transpl Int. 2009;22(8):780-797.
3. Axelrod DA, Kalbfleisch JD, Sun RJ, et al. Innovations in the assessment of transplant center performance: implications for quality improvement. Am J Transplant. 2009;9:959-969.
4. Volk ML, Biggins SW, Huang MA, Argo CK, Fontana RJ, Anspach RR. Decision making in liver transplant selection committees: a multicenter study. Ann Intern Med. 2011;155(8):503-508.
5. Volk ML, Hagan M. Organ quality and quality of life after liver transplantation. Liver Transpl. 2011;17(12):1443-1447.
6. Melloul E, Lesurtel M, Carr BI, Clavien PA. Developments in liver transplantation for hepatocellular carcinoma. Semin Oncol. 2012;39(4):510-521.
7. Dutkowski P, Schlegel A, Slankamenac K, et al. The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score. Ann Surg. 2012;256(5):861-868; discussion 868-869.
8. Zhai Y, Petrowsky H, Hong JC, Busuttil RW, Kupiec-Weglinski JW. Ischaemia-reperfusion injury in liver transplantation-from bench to bedside. Nat Rev Gastroenterol. 2012;10:79-89.
9. Bahde R, Spiegel HU. Hepatic ischaemia-reperfusion injury frombench to bedside. Br J Surg. 2010;97(10):1461-1475.
10. Ko JS, Gwak MS, Choi SJ, et al. The effects of desflurane and propofolremifentanil on postoperative hepatic and renal functions after right hepatectomy in liver donors. Liver Transpl. 2008;14(8):1150-1158.
11. Beck-Schimmer B, Breitenstein S, Urech S, et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg. 2008;248(6):909-918.
12. Ko JS, Gwak MS, Choi SJ, et al. The effects of desflurane and sevoflurane on hepatic and renal functions after right hepatectomy in living donors. Liver Transpl. 2010;23(7):736-744.
13. Beck-Schimmer B, Breitenstein S, Bonvini JM, et al. Protection of pharmacological postconditioning in liver surgery: results of a prospective randomized controlled trial. Ann Surg. 2012;256(5):837-844.
14. Balzan SM, Gava VG, Rieger A, et al. Ischemic versus pharmacologic hepatic preconditioning. J Surg Res. 2014;191(1):134-139.
15. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
16. De Hert SG. Cardioprotection in anesthesia. Minerva Anestesiol. 2008;74(6):259-270.
17. Vinten-Johansen J, Shi W. Preconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions. J Cardiovasc Pharmacol Ther. 2011;16(3-4):260-266.
18. Azoulay D, Lucidi V, Andreani P, et al. Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study. J Am Coll Surg. 2006;202(2):203-211.
19. Winbladh A, Bjornsson B, Trulsson L, Offenbartl K, Gullstrand P, Sandstrom P. Ischemic preconditioning prior to intermittent Pringle maneuver in liver resections. J Hepatobiliary Pancreat Sci. 2012;19(2):159-170.
20. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-213.
21. Kremers WK, van IM, Kim WR, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology. 2004;39(3):764-769.
22. Urata K, Kawasaki S, Matsunami H, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology. 1995;21(5):1317-1321.
23. Lemke AJ, Brinkmann MJ, Schott T, et al. Living donor right liver lobes: preoperative CT volumetric measurement for calculation of intraoperative weight and volume. Radiology. 2006;240(3):736-742.
24. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant. 2010;10(2):372-381.
25. Stockmann M, Lock JF, Malinowski M, et al. How to define initial poor graft function after liver transplantation?-a new functional definition by the LiMAx test. Transplant Int. 2010;23(10):1023-1032.
26. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg. 2007;246(6):940-946; discussion 946-948.
27. Clavien PA, Selzner M, Rudiger HA, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg. 2003;238(6): 843-850; discussion 851-842.
28. Baskin-Bey ES, Washburn K, Feng S, et al. Clinical trial of the Pan-Caspase inhibitor, IDN-6556, in human liver preservation injury. Am J Transplant. 2007;7(1):218-225.
29. Landoni G, Fochi O, Bignami E, et al. Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care Cardiovasc Anesth. 2009;1(4):34-43.
30. Steadman RH. Anesthesia for liver transplant surgery. Anesthesiol Clin North America. 2004;22(4):687-711.
31. Landoni G, Biondi-Zoccai GG, Zangrillo A, et al. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth. 2007;21(4):502-511.
32. Song JC, Sun YM, Yang LQ, Zhang MZ, Lu ZJ, Yu WF. A comparison of liver function after hepatectomy with inflow occlusion between sevoflurane and propofol anesthesia. Anesth Analg. 2010;111(4):1036-1041.
33. Minou AF, Dzyadzko AM, Shcherba AE, Rummo OO. The influence of pharmacological preconditioning with sevoflurane on incidence of early allograft dysfunction in liver transplant recipients. Anesthesiol Res Pract. 2012;2012:930487.
34. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6(4):783-790.